Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 19 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Dr. De Ruyter – Dr. Luyckx from Gent, company number BE0800307903, closed financial year 2025 with a result of € 697,698 after tax. For that financial year Dr. De Ruyter – Dr. Luyckx recorded a gross margin of € 960,859 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € 496,812 to € 697,698. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.
€ 1.2 million
▲ 139% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 697,698
▲ 40% vs 2024
Profit after tax over the fiscal year.
€ 78,215
▼ 53% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.2 million.
People and assets in 2025
€ 36,013
▼ 14% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 406,700
▼ 11% vs 2024
€ 49,800 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.
€ 11,397
▼ 23% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 391,977
▲ 154% vs 2024
Taxes, VAT and social contributions still to pay.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 795,328 | € 960,859 | ▲ 21% |
| Profit after taxes | € 496,812 | € 697,698 | ▲ 40% |
| Equity | € 501,812 | € 1,199,510 | ▲ 139% |
| Total debts | € 627,437 | € 810,074 | ▲ 29% |
| Cash | € 166,876 | € 78,215 | ▼ 53% |
| Land & buildings | € 555,182 | € 558,076 | ▲ 1% |
| Retained profit | € 496,812 | € 1,194,510 | ▲ 140% |
| Bank debt | € 456,500 | € 406,700 | ▼ 11% |
| Balance sheet total | € 1,129,250 | € 2,009,584 | ▲ 78% |
Key figures of Dr. De Ruyter – Dr. Luyckx, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr. De Ruyter – Dr. Luyckx?
What happened at Dr. De Ruyter – Dr. Luyckx in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 697,698 (▲ 40% vs 2024). Source: NBB ↗
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
- Geert Luckx became a director. NBB
- Nele De Ruyter became a director. NBB
In short
From € 496,812 profit in 2024 to € 697,698 profit in 2025.
Paid € 383,962 in corporate taxes since 2024.
Best year ever: 2025, with € 697,698 profit.
Management
Behind Dr. De Ruyter – Dr. Luyckx are Geert Luckx and Nele De Ruyter.
Directors
According to the 2025 annual accounts
Geert Luckx
Director
since 2022
Nele De Ruyter
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Galeipad 7
9000 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0800.307.903
- VAT number
- BE 0800.307.903
- Registered office
- Galeipad 7, 9000 Gent
- Names & denominations
- Dr. De Ruyter – Dr. Luyckx
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 April 2023
- Peppol
- Active · Active since 10 Jan 2025
- Activities · NACE
Activiteiten van medisch specialisten
Overige vormen van onderwijs
Overige zakelijke dienstverlening, neg